These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 21392207)
1. Screening for prostate cancer: an updated Cochrane systematic review. Ilic D; O'Connor D; Green S; Wilt TJ BJU Int; 2011 Mar; 107(6):882-91. PubMed ID: 21392207 [TBL] [Abstract][Full Text] [Related]
2. Screening for prostate cancer. Ilic D; Neuberger MM; Djulbegovic M; Dahm P Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794 [TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer. Ilic D; O'Connor D; Green S; Wilt T Cochrane Database Syst Rev; 2006 Jul; (3):CD004720. PubMed ID: 16856057 [TBL] [Abstract][Full Text] [Related]
4. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. Hayes JH; Barry MJ JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604 [TBL] [Abstract][Full Text] [Related]
5. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. Ilic D; Djulbegovic M; Jung JH; Hwang EC; Zhou Q; Cleves A; Agoritsas T; Dahm P BMJ; 2018 Sep; 362():k3519. PubMed ID: 30185521 [TBL] [Abstract][Full Text] [Related]
7. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis. Pron G Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236 [TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer: a Cochrane systematic review. Ilic D; O'Connor D; Green S; Wilt T Cancer Causes Control; 2007 Apr; 18(3):279-85. PubMed ID: 17206534 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740 [TBL] [Abstract][Full Text] [Related]
11. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Lin K; Lipsitz R; Miller T; Janakiraman S; Ann Intern Med; 2008 Aug; 149(3):192-9. PubMed ID: 18678846 [TBL] [Abstract][Full Text] [Related]
12. PSA-based screening for prostate cancer. Too many adverse effects. Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259 [TBL] [Abstract][Full Text] [Related]
13. Lycopene for the prevention of prostate cancer. Ilic D; Forbes KM; Hassed C Cochrane Database Syst Rev; 2011 Nov; 2011(11):CD008007. PubMed ID: 22071840 [TBL] [Abstract][Full Text] [Related]